Women's Imaging

Prospective trials comparing clinical outcomes of occasionally screened low-risk women with outcomes of low-risk women screened annually may overlook or misidentify breast cancers that exist but haven’t advanced, according to a new editorial. 

Has overuse of mammography created an epidemic of breast cancer pseudo-survivorship? That was the provocative question asked in a recent editorial published by Forbes.

A $2.5 million grant from the National Institutes of Health/National Cancer Institute will be given to the University of Oklahoma (OU) and Mercy Hospital Oklahoma City to go toward the development of new short-term breast cancer risk prediction models.

Who doesn’t like getting things for free? It’s even better when the freebies are used to incentivize patients to quit smoking or eat healthy. But should those gift cards, event tickets and t-shirts be used to get women to come in for a mammogram?

Research has once again shown that false-positive screening mammography results lead to increased anxiety for the women that receive them, and that these feelings can last for months. But how much should we fear the fear itself?

Imaging software being developed at Rice University in Houston could offer fast, accurate diagnosis of breast cancer without the need for a specialist, according to a study published in Breast Cancer Research.

A study published last year in the Lancet showing the merits of treating breast cancer with intraoperative radiation therapy offered hope that the technique could be a safer alternative to traditional treatment. But not everybody is convinced.

Last week, a major study on the risks of ductal carcinoma in situ (DCIS) was published in JAMA Oncology. The results spurred the New York Times editorial section to run not one, but four different commentaries on the results.

A major study this week in JAMA Oncology, which looked at mortality rates following a diagnosis of ductal carcinoma in situ (DCIS), provided some important insights and challenged preconceived notions. It also spurred even more questions.

In the discussions and debates around the optimal breast cancer screening strategies, overdiagnosis and overtreatment concerns loom large. Now, a study published in JAMA Oncology might be cause to reevaluate the detection and treatment of ductal carcinoma in situ (DCIS), or stage 0 cancer.

Prior to ordering multiple x-rays, CTs, fluoroscopies or any combination thereof, physicians treating pregnant women who may have suffered musculoskeletal injuries should consult with a medical physicist to discuss cumulative radiation dosing. However, excepting for such scenarios as well as for pelvic CTs, radiographic exams are generally safe for both mom and baby-to-be. 

Close to 70 percent of aging women at risk of osteoporosis don’t bother to have their bone density checked with the current clinical standard, dual-energy x-ray absorptiometry (DXA).